Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule, Zephir Inhaler Device

NCT06254664 is registered in ClinicalTrials.gov with Xiromed LLC as lead sponsor.

NCT NCT06254664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06254664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule, Zephir Inhaler Device
Lead sponsor
Xiromed LLC
Phase
Phase 1
Overall status
Completed
Start date
October 3, 2022
Completion date
October 27, 2023
Enrollment
116 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

copd